Edition:
United States

People: Kimberly-Clark Corp (KMB.N)

KMB.N on New York Stock Exchange

114.27USD
1:52pm EST
Change (% chg)

$0.87 (+0.77%)
Prev Close
$113.40
Open
$113.38
Day's High
$114.43
Day's Low
$113.38
Volume
145,845
Avg. Vol
473,222
52-wk High
$138.86
52-wk Low
$111.32

Read, Ian 

Mr. Ian C. Read is Independent Director of Kimberly-Clark Corporation. Mr. Read was elected Chairman of the Board and Chief Executive Officer in December 2011 and President and Chief Executive Officer in December 2010, of Pfizer, Inc., a drug manufacturer. Mr. Read joined Pfizer in 1978 in its financial organization. He worked in Latin America through 1995, holding positions of increasing responsibility, and was appointed President of the Pfizer International Pharmaceuticals Group, Latin America/Canada in 1996. In 2000, Mr. Read was named Executive Vice President of Europe/Canada and was named a corporate Vice President in 2001. In 2006, he was named Senior Vice President of Pfizer, as well as Group President of its Worldwide Biopharmaceutical Businesses.

Basic Compensation

Total Annual Compensation, USD 90,000
Restricted Stock Awards, USD 175,000
Long-Term Incentive Plans, USD --
All Other, USD 720
Fiscal Year Total, USD 265,720

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Thomas Falk

12,060,500

Maria Henry

3,446,230

Michael Hsu

4,009,000

Anthony Palmer

2,608,060

Elane Stock

3,895,980

Kimberly Underhill

--
As Of  30 Dec 2015